GluFormer was also applied to data from different types of CGM devices and a variety of underlying disorders to test its robustness in different scenarios. The study also compared the model's ...

Coming off what it’s described as its “best year ever,” the continuous glucose monitoring provider Dexcom is now looking to expand its work among people with Type 2 diabetes in a new ...